UCL News


New drug offers hope to women with ovarian cancer

5 November 2013

“While the increase in survival may seem modest, this is a significant finding for women with advanced ovarian cancer. Cediranib is the first drug of its kind that has been shown to delay tumour progression and improve overall survival in ovarian cancer that has returned,” said Professor Jonathan Ledermann (UCL CRUK Cancer Trials Centre). Read: Telegraph